Viewing StudyNCT00171301



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171301
Status: COMPLETED
Last Update Posted: 2011-08-31
First Post: 2005-09-12

Brief Title: Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis Study Amended to 2-year Duration
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-06
Start Date Type: None
Primary Completion Date: 2008-05
Primary Completion Date Type: ACTUAL
Completion Date: 2008-05
Completion Date Type: ACTUAL
First Submit Date: 2005-09-12
First Submit QC Date: September 14 2005
Study First Post Date: 2005-09-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2011-07-29
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-08-28
Last Update Post Date: 2011-08-31
Last Update Post Date Type: ESTIMATED